Literature DB >> 1577124

Retinal ganglion cell degeneration following loss of postsynaptic target neurons in the dorsal lateral geniculate nucleus of the adult cat.

H E Pearson1, D J Stoffler.   

Abstract

Kainic acid was used to produce selective degeneration of neurons in the dorsal lateral geniculate nucleus of the adult cat. This degeneration mimics the rapid loss of geniculate neurons seen after visual cortex ablation in the neonate. Following survivals of 2, 4, or 6 months, the geniculate was injected with horseradish peroxidase and the retinae were examined for the presence of retrogradely labeled cells. Analysis of ganglion cell density in peripheral nasal retina revealed a 58% loss of cells overall at 6 months. The proportion of cells labeled with horseradish peroxidase decreased more rapidly, until none were labeled at 6 months. Separate analysis of small, medium, and large ganglion cell populations revealed that only medium-sized cells were lost at 2 months whereas both medium and large cells were lost at 4 and 6 months. By 6 months, 92% of medium cells and 65% of large cells had degenerated. These results show that mature retinal ganglion cells in the cat maintain a dependence on target integrity for their continued survival. When the appropriate target is lost, the ganglion cells respond first by axon terminal retraction and then by cell death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577124     DOI: 10.1016/0014-4886(92)90164-l

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury.

Authors:  Arthur J Weber; Suresh Viswanáthan; Chidambaram Ramanathan; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-26       Impact factor: 4.799

2.  Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma.

Authors:  Jian-He Xiao; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

Review 3.  Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina.

Authors:  A J Weber; C D Harman; S Viswanathan
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

4.  BDNF treatment and extended recovery from optic nerve trauma in the cat.

Authors:  Arthur J Weber; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-09       Impact factor: 4.799

Review 5.  Neuroprotection in glaucoma.

Authors:  Sushil K Vasudevan; Viney Gupta; Jonathan G Crowston
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

6.  Blue Light-Induced Retinal Neuronal Injury and Amelioration by Commercially Available Blue Light-Blocking Lenses.

Authors:  Nagarajan Theruveethi; Bang Viet Bui; Manjunath B Joshi; Manna Valiathan; Shonraj Ballae Ganeshrao; Sivakumar Gopalakrishnan; Shama Prasada Kabekkodu; Shailaja S Bhat; Sudarshan Surendran
Journal:  Life (Basel)       Date:  2022-02-07

7.  Loss of AP-2delta reduces retinal ganglion cell numbers and axonal projections to the superior colliculus.

Authors:  Xiaodong Li; Frédéric Gaillard; Elizabeth A Monckton; Darryl D Glubrecht; Amit R L Persad; Markus Moser; Yves Sauvé; Roseline Godbout
Journal:  Mol Brain       Date:  2016-06-04       Impact factor: 4.041

8.  Optic Nerve Engraftment of Neural Stem Cells.

Authors:  Jiun L Do; Salam Allahwerdy; Ryan Caezar C David; Robert N Weinreb; Mark H Tuszynski; Derek S Welsbie
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.